Stockreport

Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering tra [Read more]